Pilot Remote Therapeutic Monitoring in Cancer Patients

Launched by SHIRLEY RYAN ABILITYLAB · May 28, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Pilot Remote Therapeutic Monitoring in Cancer Patients," aims to understand how exercise and physical activity can benefit individuals undergoing cancer treatment. The study will explore how effective remote monitoring tools, like activity trackers and a mobile app, are in helping patients reach their personal exercise goals, such as walking a certain number of steps each day or completing weekly workouts. The researchers want to see how well these tools work for both patients and healthcare providers, making sure they are easy to use and helpful.

To participate in this study, you need to be between the ages of 65 and 74, have a cancer diagnosis (and be receiving treatment like chemotherapy or radiation), and be able to move around independently, possibly with the help of a cane or walking stick. You'll also need a smartphone and a desire to increase or maintain your physical activity. Participants will use the activity trackers and app to monitor their exercise over three months. It's important to note that this study is not yet recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Are ambulatory as their primary means of mobility without an assistive device except for single point cane or walking sticks in community
• • Have a diagnosis of cancer (undergoing chemo, radiation, surgery, immunotherapy, or cell therapy (transplants and Chimeric Antigen Receptor t-cell therapy (CAR-T)) or in cancer survivorship
• • Participating in Outpatient rehabilitation services at time of enrollment, or recommended by physician for participation in study
• • Have a goal to increase or maintain physical activity (e.g., steps per day or minutes of moderate to vigorous exercise per week) or strength bouts - personal goal and willingness to address physical activity
• • Have a smart phone
• • Willing to accept Datos' Terms and Conditions
• Exclusion Criteria:
• • o Individuals with cognitive or communication disorders (including dementia) which would limit their ability to interact with the RTM in this pilot phase